submit to the journals
Leading the Debate on the Advances in Healthcare
Search Site
EURETINA Highlights
flipper_slider
Pravin Dugel, EURETINA 2018 – Brolucizumab For Neovascular Age-related Macular Degeneration
At this year’s EURETINA congress, we caught up with Dr Pravin Dugel to discuss neovascular...
Hemal Mehta, EURETINA 2018 - Wet Age-related Macular Degeneration and the PanOptica Eye Drop
Hemal Mehta speaks to us about the current management options for wet age-related macular...
EURETINA 2017 - Hemal Mehta Interview Part 2
Hemal Mehta discusses the currently available intravitreal steroid therapies for the treatment of...
EURETINA 2017 - Manish Nagpal Interview
Manish Nagpal discusses the latest advances in OCT angiography and the current and future...
Editor's Choice
Hemal Mehta speaks to us about the current management options for wet age-related macular degeneration (AMD), including intravitreal injections of anti-VEGF agents and other injection-based therapy, and their treatment...
EURETINA Highlights Videos
At this year’s EURETINA congress, we caught up with Dr Pravin Dugel to discuss neovascular age-related macular degeneration (nAMD). Dr Dugel suggests that while there have been recent advances in the treatment of nAMD, there is still a need to obtain better efficacy and find drugs that maintain...
Ulrike Stolba discusses reusable lenses and their problems, and also her first impressions of the new OCULUS HD Disposable LenZ and its suitability for a range of different kinds of surgery.
Questions:
1. What were your first impressions of the new OCULUS HD Disposable LenZ when you started...
Hemal Mehta speaks to us about the current management options for wet age-related macular degeneration (AMD), including intravitreal injections of anti-VEGF agents and other injection-based therapy, and their treatment burden. He then discusses the new PanOptica Eye Drop, a topical treatment for...
Hemal Mehta discusses the currently available intravitreal steroid therapies for the treatment of diabetic macular oedema and the supporting clinical trial and real-world evidence.
Manish Nagpal discusses the latest advances in OCT angiography and the current and future diagnostic applications.
Baruch Kuppermann discusses the early use of intravitreal steroids for patients with diabetic macular edema.
Albert Augustin discusses the use of anti-VEGF agents and intravitreal steroids in the treatment of diabetic macular edema.
Pravin Dugel discusses his highlights from EURETINA 2017.
Pravin Dugel discusses the unmet need in the treatment of neovascular AMD and the research into new agents, such as brolucizumab.
Hemal Mehta discusses the strengths and limitations of anti-VEGF therapy and when intravitreal steroids should be considered.
Roberto Gallego-Pinazo discusses multi-modal retinal imaging and how he implements it in his day-to-day clinical practice.
Anat Loewenstein discusses intravitreal and laser therapies in the treatment of diabetic macular oedema.
European Ophthalmic Review's Editorial Board member Anat Loewenstein shares her highlights from the 2017 EURETINA meeting.
